University Hospitals Cleveland Medical Center

University Hospitals Cleveland Medical Center was paid $156.83M by Medicaid between Jan 2018 and Dec 2024, across 805 billing codes. Its largest line is J9271, Injection, pembrolizumab, 1 mg — 9.3% of everything it billed.

33Billing provider infoUNIVERSITY HOSPITALS CLEVELAND MEDICAL CENTER
CLEVELAND, OH 44106

33aNPI1043397292assigned 11/01/2006

33bProvider typeGeneral Acute Care Hospital

28Total paid$156.83M

24GClaims2,733,531

24DCodes billed805

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other General Acute Care Hospital providers in Ohio

Rank by total paid#7 of 101

Median peer was paid$22.32M

This provider vs. median7.0×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official SCHILLERO, ANTHONY controls 20+ related entities in our dataset. Read more

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	231,001	$11.60M
2019	212,717	$11.47M
2020	165,849	$12.33M
2021	192,447	$12.38M
2022	182,630	$11.71M
2023	990,500	$57.28M
2024incomplete	758,387	$40.07M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
J9271	Injection, pembrolizumab, 1 mg	9.3%	1,896	1,185	$14.60M
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	8.3%	89,345	80,982	$13.03M
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	8.2%	98,130	85,631	$12.78M
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	6.6%	67,712	60,780	$10.43M
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	5.9%	71,776	62,589	$9.24M
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	5.2%	55,703	47,270	$8.09M
76816	Ultrasound, pregnant uterus, real time with image documentation, follow-up	2.9%	32,383	29,657	$4.54M
96361	Intravenous infusion, hydration; each additional hour	2.7%	14,788	10,797	$4.27M
70450	Computed tomography, head or brain; without contrast material	2.4%	13,277	10,826	$3.81M
99215	Doctor's office visit, returning patient (complex)Prolong outpt/office vis	2.0%	26,191	20,822	$3.14M
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	1.8%	33,063	13,736	$2.81M
76819	Fetal biophysical profile; without non-stress testing	1.6%	27,360	21,445	$2.51M

793 more codes

77386		1.4%	5,947	$2.18M
76811	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed	1.3%	12,603	$2.04M
95810	Polysomnography; sleep staging with 4 or more additional parameters	1.1%	2,540	$1.78M
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	1.1%	12,464	$1.75M
59025	Fetal non-stress test	1.1%	9,830	$1.74M
D2930	Prefabricated stainless steel crown - primary tooth	1.1%	3,239	$1.70M
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	1.0%	10,081	$1.58M
41899	Unlisted procedure, dentoalveolar structures	<1%	1,468	$1.45M
76801		<1%	9,322	$1.41M
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	<1%	5,031	$1.32M
74177	Computed tomography, abdomen and pelvis; with contrast material	<1%	8,130	$1.31M
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	<1%	12,028	$1.29M
J9299	Injection, nivolumab, 1 mg	<1%	227	$1.11M
G0378	Hospital observation service, per hour	<1%	17,310	$1.05M
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	<1%	3,722	$853K
92507	Treatment of speech, language, voice, communication, and/or auditory processing disorder	<1%	9,430	$815K
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	<1%	3,080	$808K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	6,267	$759K
G0463	Hospital outpatient clinic visit for assessment and management of a patient	<1%	37,643	$753K
99395	Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years	<1%	5,598	$749K
92557		<1%	9,574	$718K
80053	Comprehensive metabolic panel	<1%	106,546	$696K
76813		<1%	5,605	$663K
D3220	Therapeutic pulpotomy (excluding final restoration) - removal of pulp coronal to the dentinocemental junction	<1%	1,193	$656K
71275	Computed tomographic angiography, chest, with contrast material	<1%	2,261	$639K
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	2,953	$596K
97530	Therapeutic activities, direct patient contact, each 15 minutes	<1%	7,822	$580K
70553	Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences	<1%	2,078	$576K
36512		<1%	397	$574K
J1050	Injection, medroxyprogesterone acetate, 1 mg	<1%	6,990	$551K
69436	Tympanostomy (requiring insertion of ventilating tube), general anesthesia	<1%	323	$538K
95886		<1%	1,894	$519K
J7307	Etonogestrel (contraceptive) implant system, including implant and supplies	<1%	512	$509K
J0897	Injection, denosumab, 1 mg	<1%	449	$505K
71260	Computed tomography, thorax, diagnostic; with contrast material	<1%	3,883	$503K
92587		<1%	7,711	$493K
78815	Positron emission tomography (PET) for limited area imaging	<1%	815	$492K
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	<1%	4,316	$488K
76820		<1%	6,144	$481K
Q5107	Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg	<1%	896	$473K
99281	Emergency department visit for the evaluation and management, self-limited or minor	<1%	2,999	$472K
95811		<1%	698	$463K
77300		<1%	917	$460K
77295		<1%	523	$428K
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	<1%	912	$425K
92550		<1%	5,168	$414K
77334		<1%	1,156	$409K
J9144	Injection, daratumumab, 10 mg and hyaluronidase-fihj	<1%	82	$401K
45385	Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s)	<1%	676	$400K
95806		<1%	627	$394K
77412		<1%	2,731	$392K
82805		<1%	12,290	$388K
74176	Computed tomography, abdomen and pelvis; without contrast material	<1%	1,495	$370K
76817	Ultrasound, pregnant uterus, real time with image documentation, transvaginal	<1%	5,019	$367K
66984	Extracapsular cataract removal with insertion of intraocular lens prosthesis	<1%	572	$339K
J9022	Injection, atezolizumab, 10 mg	<1%	55	$338K
92567		<1%	8,564	$336K
96367		<1%	3,457	$334K
71046	Radiologic examination, chest; 2 views	<1%	23,875	$320K
76770		<1%	1,655	$309K
D7140	Extraction, erupted tooth or exposed root	<1%	1,247	$307K
76805	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation	<1%	2,582	$306K
J2506	Injection, pegfilgrastim, excludes biosimilar, 0.5 mg	<1%	521	$300K
76815	Ultrasound, pregnant uterus, real time with image documentation, limited	<1%	3,659	$298K
96416		<1%	1,133	$298K
99282	Emergency department visit for the evaluation and management, low to moderate severity	<1%	2,449	$296K
96415		<1%	1,943	$287K
97161		<1%	5,383	$278K
95782		<1%	355	$262K
J1745	Injection, infliximab, excludes biosimilar, 10 mg	<1%	101	$260K
77336		<1%	2,378	$258K
77063	Screening digital breast tomosynthesis, bilateral	<1%	5,173	$257K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	13,859	$257K
86850		<1%	12,850	$255K
77290		<1%	457	$241K
80048	Basic metabolic panel (calcium, ionized)	<1%	18,583	$238K
90853	Group psychotherapy (other than of a multiple-family group)	<1%	2,434	$233K
P9016	Red blood cells, leukocytes reduced, each unit	<1%	1,070	$221K
70491		<1%	782	$215K
88185		<1%	5,281	$215K
45380	Colonoscopy, flexible; with biopsy, single or multiple	<1%	487	$214K
97140	Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage)	<1%	8,619	$213K
76642		<1%	2,387	$212K
36430		<1%	1,671	$203K
77301		<1%	244	$199K
J7298	Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg	<1%	206	$195K
J9173	Injection, durvalumab, 10 mg	<1%	58	$194K
76830	Ultrasound, transvaginal	<1%	3,601	$192K
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	2,035	$189K
70551	Magnetic resonance imaging, brain; without contrast material	<1%	1,013	$178K
87636	Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B	<1%	9,138	$177K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	135,133	$171K
70496		<1%	610	$167K
93308		<1%	709	$163K
36556		<1%	420	$162K
95816		<1%	898	$158K
73721	Magnetic resonance imaging, any joint of lower extremity; without contrast material	<1%	641	$155K
73610		<1%	4,273	$151K
71250		<1%	1,648	$149K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	41,590	$148K
93970		<1%	982	$147K
84484		<1%	31,028	$146K
J2997	Injection, alteplase recombinant, 1 mg	<1%	875	$145K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	51,459	$145K
99396	Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years	<1%	1,124	$144K
73630		<1%	4,056	$140K
11042	Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm	<1%	1,229	$140K
86900		<1%	12,985	$140K
19083		<1%	156	$137K
76536		<1%	1,179	$135K
C1713	Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable)	<1%	1,108	$135K
97165		<1%	1,849	$132K
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	13,871	$132K
31575		<1%	689	$127K
P9040	Red blood cells, leukocytes reduced, irradiated, each unit	<1%	833	$122K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	14,380	$122K
70498		<1%	876	$117K
74183		<1%	531	$114K
93971		<1%	1,436	$114K
J0561	Injection, penicillin g benzathine, 100,000 units	<1%	410	$111K
90937		<1%	273	$108K
88184		<1%	2,719	$107K
93975		<1%	745	$107K
0002A		<1%	3,126	$106K
77387		<1%	2,171	$106K
0001A		<1%	3,255	$105K
92579		<1%	3,406	$103K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	12,477	$101K
72148	Magnetic resonance imaging, lumbar spine; without contrast material	<1%	747	$100K
D1351	Sealant - per tooth	<1%	234	$99K
J9306	Injection, pertuzumab, 1 mg	<1%	23	$99K
78452	Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress	<1%	257	$98K
J9305	Injection, pemetrexed, not otherwise specified, 10 mg	<1%	415	$94K
01922		<1%	413	$94K
72141		<1%	532	$92K
80069		<1%	9,282	$91K
D2391	Resin-based composite - one surface, posterior, primary or permanent	<1%	189	$90K
95924		<1%	246	$89K
45378	Colonoscopy, flexible; diagnostic, including collection of specimen(s)	<1%	220	$89K
J1569	Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg	<1%	174	$88K
71045	Radiologic examination, chest; single view	<1%	13,576	$87K
73030		<1%	3,457	$85K
92585		<1%	364	$85K
73560		<1%	1,911	$83K
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	<1%	44,766	$83K
90651		<1%	442	$82K
76700	Ultrasound, abdominal, real time with image documentation; complete	<1%	414	$82K
97112	Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination	<1%	2,532	$81K
88341		<1%	1,523	$80K
73130		<1%	3,544	$80K
71271		<1%	517	$80K
97016		<1%	2,029	$78K
72197		<1%	300	$75K
77067	Screening mammography, bilateral, including computer-aided detection	<1%	5,194	$75K
J1756	Injection, iron sucrose, 1 mg	<1%	3,090	$73K
85027		<1%	21,435	$73K
97113		<1%	856	$72K
99291	Critical care, evaluation and management of the critically ill patient, first 30-74 minutes	<1%	572	$71K
J7297	Levonorgestrel-releasing intrauterine contraceptive system (liletta), 52 mg	<1%	98	$71K
70486		<1%	2,081	$71K
10060		<1%	412	$70K
74018		<1%	1,410	$69K
82947		<1%	35,420	$69K
73562		<1%	1,676	$69K
73502		<1%	2,139	$68K
97116		<1%	1,761	$68K
72110		<1%	1,207	$68K
73110		<1%	2,412	$64K
93017		<1%	807	$64K
36415	Collection of venous blood by venipuncture	<1%	67,941	$64K
73590		<1%	2,661	$64K
97162		<1%	1,184	$63K
77280		<1%	552	$63K
76982		<1%	1,520	$62K
97535	Self-care/home management training, each 15 minutes	<1%	1,687	$62K
77338		<1%	248	$61K
P9045	Infusion, albumin (human), 5%, 250 ml	<1%	202	$60K
90715		<1%	4,547	$59K
94060		<1%	591	$59K
88307		<1%	814	$59K
12001		<1%	373	$59K
90870		<1%	123	$58K
73564		<1%	2,906	$57K
Q5117	Injection, trastuzumab-anns, biosimilar, (kanjinti), 10 mg	<1%	206	$57K
72125	Computed tomography, cervical spine; without contrast material	<1%	5,165	$56K
94618		<1%	673	$56K
11982		<1%	264	$56K
83605		<1%	21,691	$54K
80320		<1%	2,715	$51K
75574		<1%	191	$51K
75561		<1%	181	$50K
Q0138	Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)	<1%	398	$49K
58558		<1%	46	$49K
H2019	Therapeutic behavioral services, billed per 15 minutes	<1%	842	$49K
99152		<1%	3,567	$49K
20610		<1%	384	$47K
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	<1%	1,951	$47K
74230		<1%	253	$47K
96523		<1%	1,369	$46K
74174		<1%	667	$46K
76000		<1%	427	$46K
86901		<1%	12,993	$46K
88175	Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer	<1%	3,379	$45K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	6,505	$45K
96376		<1%	9,550	$45K
93296		<1%	2,043	$45K
36591		<1%	3,806	$45K
97802		<1%	475	$45K
29581		<1%	439	$44K
96375	Therapeutic injection; each additional sequential IV push	<1%	34,440	$44K
73552		<1%	1,799	$44K
77062		<1%	1,023	$43K
92626		<1%	577	$43K
93880		<1%	444	$43K
82728		<1%	7,014	$42K
58300		<1%	430	$42K
81025		<1%	51,376	$42K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	14,367	$41K
72050		<1%	692	$40K
83735		<1%	21,600	$40K
Q5103	Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg	<1%	31	$39K
73140		<1%	633	$38K
12002		<1%	263	$38K
83021		<1%	4,434	$37K
86920		<1%	1,871	$37K
77080		<1%	588	$37K
92526		<1%	604	$35K
72100		<1%	875	$35K
73090		<1%	1,501	$34K
70544		<1%	232	$34K
90791	Psychiatric diagnostic evaluation	<1%	181	$34K
93242		<1%	290	$33K
72170		<1%	1,811	$33K
83615		<1%	12,345	$33K
T1002	Rn services, up to 15 minutes	<1%	331	$33K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	8,323	$33K
93325		<1%	415	$33K
92523		<1%	379	$32K
72082		<1%	529	$32K
77061		<1%	751	$32K
87637	Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV	<1%	821	$32K
85610		<1%	26,517	$32K
70487		<1%	119	$32K
94726		<1%	612	$32K
J3490	Unclassified drugs	<1%	10,063	$31K
93922		<1%	451	$31K
58301		<1%	282	$31K
77072		<1%	311	$31K
87536		<1%	1,886	$31K
92551		<1%	283	$31K
72131		<1%	1,010	$31K
92604		<1%	836	$30K
94729		<1%	755	$30K
76818		<1%	321	$30K
57454		<1%	91	$30K
73700		<1%	254	$30K
86780		<1%	5,653	$30K
76981		<1%	455	$30K
95885		<1%	91	$30K
73221		<1%	139	$29K
59430		<1%	252	$29K
87081		<1%	2,890	$29K
95923		<1%	233	$28K
87086	Culture, bacterial; quantitative colony count, urine	<1%	11,031	$28K
84443	Thyroid stimulating hormone (TSH)	<1%	7,753	$28K
62323		<1%	99	$28K
12011		<1%	185	$28K
82330		<1%	17,582	$27K
73080		<1%	1,147	$26K
86141		<1%	2,581	$26K
J3535	Drug administered through a metered dose inhaler	<1%	1,046	$26K
38222		<1%	58	$26K
J1950	Injection, leuprolide acetate (for depot suspension), per 3.75 mg	<1%	15	$26K
91200		<1%	209	$25K
99153	Mod sedat endo service >5yrs	<1%	2,133	$25K
11045		<1%	73	$25K
31579		<1%	87	$24K
D2934		<1%	41	$24K
58661		<1%	18	$24K
77470		<1%	46	$23K
D2330		<1%	49	$23K
87800		<1%	5,137	$23K
72128		<1%	815	$23K
77065	Tomosynthesis, mammo	<1%	1,129	$22K
81001		<1%	31,568	$22K
73070		<1%	520	$22K
86922		<1%	929	$22K
J9070	Cyclophosphamide, 100 mg	<1%	201	$21K
76882		<1%	194	$21K
42820	Tonsillectomy and adenoidectomy; younger than age 12	<1%	14	$21K
99406		<1%	1,082	$21K
73060		<1%	1,104	$20K
85007		<1%	2,907	$20K
78816		<1%	27	$20K
86808		<1%	1,036	$20K
90686		<1%	1,542	$20K
J1453	Injection, fosaprepitant, 1 mg	<1%	1,641	$19K
99391	Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year)	<1%	165	$19K
C8929	Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography	<1%	344	$19K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	2,319	$19K
93798		<1%	231	$19K
76870		<1%	361	$18K
83036	Hemoglobin; glycosylated (A1C)	<1%	3,983	$18K
43235		<1%	65	$18K
81003		<1%	24,641	$18K
97166		<1%	288	$17K
93350		<1%	75	$17K
94010		<1%	535	$17K
83880		<1%	6,374	$17K
86902		<1%	1,487	$17K
J1815	Injection, insulin, per 5 units	<1%	1,136	$17K
J1750	Injection, iron dextran, 50 mg	<1%	120	$16K
97010		<1%	469	$16K
90837	Psychotherapy session, about an hour	<1%	130	$16K
85045		<1%	9,046	$16K
84702		<1%	5,288	$16K
72040		<1%	316	$16K
72190		<1%	239	$16K
82607		<1%	2,082	$15K
93356		<1%	129	$15K
92611		<1%	192	$15K
96116		<1%	79	$15K
73100		<1%	342	$15K
80061	Lipid panel	<1%	2,695	$15K
J2469	Injection, palonosetron hcl, 25 mcg	<1%	3,861	$15K
J9395	Injection, fulvestrant, 25 mg	<1%	157	$15K
77066	Tomosynthesis, mammo	<1%	1,183	$14K
96401		<1%	1,308	$14K
88360		<1%	214	$14K
95911		<1%	143	$14K
0004A		<1%	373	$13K
00170	Anesthesia for intraoral procedures, including biopsy	<1%	2,654	$13K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	4,975	$13K
93246		<1%	210	$13K
96368		<1%	747	$12K
36561		<1%	20	$12K
83540		<1%	3,526	$12K
87205		<1%	3,760	$11K
J1170	Injection, hydromorphone, up to 4 mg	<1%	12,238	$11K
86832		<1%	287	$11K
0072A		<1%	283	$11K
87631		<1%	58	$11K
86140		<1%	2,047	$11K
92652		<1%	214	$11K
J8499	Prescription drug, oral, non chemotherapeutic, nos	<1%	5,841	$11K
74240		<1%	57	$10K
87210		<1%	10,323	$10K
99385		<1%	265	$10K
99392	Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years)	<1%	155	$10K
94660		<1%	89	$10K
93321		<1%	222	$10K
0012A		<1%	502	$10K
0071A		<1%	259	$10K
J9217	Leuprolide acetate (for depot suspension), 7.5 mg	<1%	56	$10K
J9045	Injection, carboplatin, 50 mg	<1%	1,311	$10K
85730		<1%	6,492	$10K
C1760	Closure device, vascular (implantable/insertable)	<1%	332	$10K
71101		<1%	411	$10K
88342		<1%	1,331	$10K
83550		<1%	3,561	$10K
31500		<1%	38	$10K
95910		<1%	61	$9K
85097		<1%	109	$9K
70360		<1%	123	$9K
82435		<1%	13,950	$9K
77073		<1%	230	$9K
84439		<1%	1,879	$9K
82077		<1%	5,584	$9K
29075		<1%	78	$8K
80143		<1%	5,260	$8K
0011A		<1%	697	$8K
72072		<1%	195	$8K
86870		<1%	300	$8K
0003A		<1%	224	$8K
97803		<1%	112	$8K
82570		<1%	2,723	$8K
J0500	Injection, dicyclomine hcl, up to 20 mg	<1%	396	$8K
86923		<1%	241	$8K
85018		<1%	10,527	$8K
80346		<1%	516	$8K
95913		<1%	58	$8K
87070		<1%	1,655	$8K
80361		<1%	741	$8K
G0121	Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk	<1%	15	$8K
72081		<1%	108	$7K
82533		<1%	1,389	$7K
86833		<1%	280	$7K
J0885	Injection, epoetin alfa, (for non-esrd use), 1000 units	<1%	322	$7K
72156		<1%	43	$7K
86803		<1%	2,555	$7K
73000		<1%	212	$7K
82784		<1%	3,285	$7K
84132		<1%	15,208	$7K
97035		<1%	67	$7K
99386		<1%	103	$7K
82024		<1%	1,012	$6K
83690		<1%	11,229	$6K
J9263	Injection, oxaliplatin, 0.5 mg	<1%	1,282	$6K
80076		<1%	1,060	$6K
C1776	Joint device (implantable)	<1%	60	$6K
58100		<1%	43	$6K
73521		<1%	182	$6K
80185		<1%	290	$6K
86334		<1%	794	$6K
90999	Dialysis (unlisted procedure)	<1%	85	$6K
92610		<1%	88	$6K
73620		<1%	154	$6K
83970		<1%	449	$6K
82378		<1%	1,211	$6K
82248		<1%	1,758	$5K
87186		<1%	2,542	$5K
84295		<1%	14,127	$5K
94762		<1%	98	$5K
J2800	Injection, methocarbamol, up to 10 ml	<1%	1,645	$5K
96402		<1%	1,046	$5K
87075		<1%	2,573	$5K
88237		<1%	77	$5K
86706		<1%	1,069	$5K
81379		<1%	14	$5K
80197		<1%	906	$5K
11981		<1%	26	$5K
77293		<1%	49	$5K
87340		<1%	1,342	$5K
J7120	Ringers lactate infusion, up to 1000 cc	<1%	25,583	$5K
76937		<1%	766	$5K
87497		<1%	656	$5K
82746		<1%	1,257	$5K
72120		<1%	138	$5K
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	2,038	$5K
82550		<1%	2,196	$5K
92524		<1%	69	$5K
J0585	Injection, onabotulinumtoxina, 1 unit	<1%	38	$5K
J1650	Injection, enoxaparin sodium, 10 mg	<1%	5,302	$5K
95819		<1%	27	$5K
84153		<1%	783	$4K
87077		<1%	1,555	$4K
99195		<1%	300	$4K
74178		<1%	14	$4K
87040		<1%	2,334	$4K
99407		<1%	126	$4K
J9060	Injection, cisplatin, powder or solution, 10 mg	<1%	392	$4K
84100		<1%	4,100	$4K
29065		<1%	40	$4K
80349		<1%	530	$4K
80179		<1%	5,214	$4K
76885		<1%	33	$4K
81382		<1%	30	$4K
82962		<1%	3,583	$4K
Q2036	Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (flulaval)	<1%	338	$4K
92950		<1%	48	$4K
86318		<1%	447	$4K
96158		<1%	44	$4K
95909		<1%	44	$4K
J8501	Aprepitant, oral, 5 mg	<1%	214	$4K
84403		<1%	509	$4K
84550		<1%	2,245	$4K
87799		<1%	830	$3K
87535		<1%	103	$3K
88350		<1%	53	$3K
J2543	Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams)	<1%	1,037	$3K
J2270	Injection, morphine sulfate, up to 10 mg	<1%	6,620	$3K
90677		<1%	95	$3K
77370		<1%	20	$3K
J9206	Injection, irinotecan, 20 mg	<1%	291	$3K
80198		<1%	287	$3K
0064A		<1%	95	$3K
73120		<1%	83	$3K
86704		<1%	602	$3K
J3260	Injection, tobramycin sulfate, up to 80 mg	<1%	171	$3K
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	30,365	$3K
86317		<1%	258	$3K
88304		<1%	419	$3K
J2704	Injection, propofol, 10 mg	<1%	9,712	$3K
00300		<1%	312	$3K
97014		<1%	68	$3K
83883		<1%	502	$3K
92014	Ophthalmological services: medical examination and evaluation, comprehensive, established patient	<1%	21	$3K
82565		<1%	429	$3K
76983		<1%	69	$3K
90656		<1%	275	$3K
J9201	Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg	<1%	233	$3K
84165		<1%	1,196	$2K
88112		<1%	309	$2K
76942		<1%	457	$2K
77001		<1%	365	$2K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	389	$2K
96409		<1%	450	$2K
Q5106	Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units	<1%	42	$2K
00731		<1%	714	$2K
84156		<1%	1,761	$2K
J1610	Injection, glucagon hydrochloride, per 1 mg	<1%	18	$2K
C9113	Injection, pantoprazole sodium, per vial	<1%	974	$2K
80365		<1%	536	$2K
A9270	Non-covered item or service	<1%	35,494	$2K
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	17,825	$2K
J1953	Injection, levetiracetam, 10 mg	<1%	442	$2K
83521		<1%	969	$2K
85384		<1%	1,565	$2K
99393	Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years)	<1%	110	$2K
76825		<1%	35	$2K
J1644	Injection, heparin sodium, per 1000 units	<1%	5,693	$2K
83010		<1%	695	$2K
J0640	Injection, leucovorin calcium, per 50 mg	<1%	81	$2K
86880		<1%	145	$2K
70547		<1%	13	$2K
87529		<1%	326	$2K
85652		<1%	1,886	$2K
88313		<1%	460	$2K
73200		<1%	13	$2K
87632		<1%	18	$2K
81002		<1%	3,156	$2K
72158		<1%	15	$2K
88346		<1%	42	$2K
82948		<1%	1,118	$2K
73660		<1%	30	$2K
85014		<1%	2,792	$2K
90662		<1%	371	$2K
J7030	Infusion, normal saline solution , 1000 cc	<1%	11,001	$2K
87522	Neg quan hep c or qual rna	<1%	183	$2K
80358		<1%	291	$2K
76604		<1%	14	$2K
85660		<1%	997	$2K
73600		<1%	58	$2K
84155		<1%	1,207	$2K
85379		<1%	1,640	$2K
82803		<1%	2,812	$2K
90472	Immunization administration, each additional vaccine (list separately)	<1%	456	$2K
12013		<1%	18	$2K
51798		<1%	288	$2K
86038		<1%	222	$2K
80354		<1%	294	$2K
82043		<1%	529	$2K
90688		<1%	119	$2K
76827		<1%	34	$1K
87101		<1%	72	$1K
86481		<1%	75	$1K
80373		<1%	263	$1K
J3411	Injection, thiamine hcl, 100 mg	<1%	911	$1K
J3475	Injection, magnesium sulfate, per 500 mg	<1%	3,972	$1K
80177		<1%	644	$1K
99204	Doctor's office visit, new patient (more involved)	<1%	12	$1K
90678		<1%	104	$1K
99401		<1%	15	$1K
82247		<1%	370	$1K
86762		<1%	133	$1K
J2274	Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg	<1%	299	$1K
C1769	Guide wire	<1%	1,352	$1K
96417		<1%	2,702	$1K
83516		<1%	41	$1K
72146		<1%	16	$1K
J7999	Compounded drug, not otherwise classified	<1%	1,556	$1K
88312		<1%	62	$1K
76821		<1%	30	$1K
96132		<1%	26	$1K
89240		<1%	148	$978.34
82977		<1%	276	$972.79
87102		<1%	315	$957.76
00840		<1%	584	$952.94
97022		<1%	32	$947.29
G0404	Electrocardiogram, routine ecg with 12 leads; tracing only, without interpretation and report, performed as a screening for the initial preventive physical examination	<1%	249	$928.92
80368		<1%	263	$923.71
C1725	Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability)	<1%	71	$899.85
82375		<1%	622	$893.19
86825		<1%	35	$881.19
80329		<1%	705	$871.58
91300		<1%	6,866	$861.80
90670		<1%	92	$858.43
J2360	Injection, orphenadrine citrate, up to 60 mg	<1%	1,851	$825.48
J3370	Injection, vancomycin hcl, 500 mg	<1%	1,750	$824.80
87467		<1%	158	$823.09
J9000	Injection, doxorubicin hydrochloride, 10 mg	<1%	80	$809.67
J2359	Injection, olanzapine, 0.5 mg	<1%	268	$795.56
83050		<1%	599	$790.71
J1642	Injection, heparin sodium, (heparin lock flush), per 10 units	<1%	5,470	$787.45
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	24,337	$783.44
J0131	Injection, acetaminophen, not otherwise specified,10 mg	<1%	930	$774.95
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	4,072	$760.59
C1887	Catheter, guiding (may include infusion/perfusion capability)	<1%	483	$741.39
84460		<1%	378	$732.60
84450		<1%	375	$715.78
80074		<1%	154	$713.52
A9575	Injection, gadoterate meglumine, 0.1 ml	<1%	4,025	$711.53
84075		<1%	371	$692.14
29125		<1%	253	$687.41
86592		<1%	115	$659.91
86301		<1%	139	$653.96
73523		<1%	22	$652.94
86364		<1%	26	$652.89
C1894	Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser	<1%	1,033	$648.76
86225		<1%	82	$628.54
J0360	Injection, hydralazine hcl, up to 20 mg	<1%	827	$622.26
76776		<1%	20	$621.96
00142		<1%	595	$615.65
87506		<1%	12	$611.68
J8540	Dexamethasone, oral, 0.25 mg	<1%	1,412	$608.24
0013A		<1%	18	$585.08
J0295	Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm	<1%	519	$583.31
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	5,063	$578.54
90833	Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on)	<1%	14	$577.62
86235		<1%	84	$570.56
84445		<1%	19	$570.23
88311		<1%	176	$567.33
74220		<1%	13	$566.50
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	<1%	1,131	$559.83
J0690	Injection, cefazolin sodium, 500 mg	<1%	4,046	$557.43
00120		<1%	37	$553.71
72157		<1%	12	$547.17
86787		<1%	46	$540.53
J0780	Injection, prochlorperazine, up to 10 mg	<1%	1,024	$539.78
72070		<1%	13	$536.71
88142		<1%	39	$528.60
82150		<1%	206	$519.23
97032		<1%	18	$512.57
95012		<1%	12	$501.65
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	12,355	$500.37
J2785	Injection, regadenoson, 0.1 mg	<1%	194	$494.89
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	11,112	$488.64
86580		<1%	14	$488.01
84145		<1%	59	$475.90
G0008	Administration of influenza virus vaccine	<1%	391	$475.67
J3420	Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg	<1%	970	$473.61
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	16,490	$463.39
86431		<1%	70	$460.65
85347		<1%	234	$455.81
86735		<1%	35	$453.25
86765		<1%	37	$453.25
80164		<1%	82	$442.27
87634		<1%	130	$435.32
J3489	Injection, zoledronic acid, 1 mg	<1%	79	$433.29
J2765	Injection, metoclopramide hcl, up to 10 mg	<1%	2,783	$425.20
J7060	5% dextrose/water (500 ml = 1 unit)	<1%	8,706	$419.81
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	<1%	755	$414.83
82010		<1%	364	$401.40
99417	Prolong home eval add 15m	<1%	686	$398.23
87015		<1%	193	$369.16
99394	Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years)	<1%	24	$355.33
82232		<1%	51	$348.74
89051		<1%	167	$338.82
83002		<1%	32	$337.16
J0689	Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg	<1%	1,057	$335.72
A9502	Technetium tc-99m tetrofosmin, diagnostic, per study dose	<1%	361	$334.66
88173		<1%	103	$330.57
82465		<1%	51	$328.07
87206		<1%	207	$326.61
86703		<1%	143	$323.36
J2920	Injection, methylprednisolone sodium succinate, up to 40 mg	<1%	720	$321.52
J1630	Injection, haloperidol, up to 5 mg	<1%	1,459	$316.68
90633		<1%	31	$307.55
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	290	$296.09
83001		<1%	18	$290.22
92555		<1%	25	$286.78
90732		<1%	20	$285.97
86308		<1%	35	$268.44
90698		<1%	53	$267.43
51702		<1%	33	$265.05
84146		<1%	15	$263.59
87185		<1%	114	$250.75
Q9957	Injection, perflutren lipid microspheres, per ml	<1%	1,164	$247.93
86300		<1%	136	$243.69
86304		<1%	21	$240.91
84540		<1%	79	$237.91
J9190	Injection, fluorouracil, 500 mg	<1%	1,786	$233.66
87449		<1%	48	$230.18
J3590	Unclassified biologics	<1%	24	$228.17
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	<1%	3,928	$226.90
82668		<1%	74	$215.81
J2919	Injection, methylprednisolone sodium succinate, 5 mg	<1%	560	$211.92
G2066	Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results	<1%	88	$208.48
82810		<1%	381	$208.10
J1720	Injection, hydrocortisone sodium succinate, up to 100 mg	<1%	285	$196.38
84300		<1%	91	$193.21
82670		<1%	13	$189.47
93290		<1%	33	$188.29
J3480	Injection, potassium chloride, per 2 meq	<1%	1,704	$187.24
80202		<1%	21	$186.27
84133		<1%	76	$186.19
J1940	Injection, furosemide, up to 20 mg	<1%	1,132	$174.28
82436		<1%	47	$162.13
A4217	Sterile water/saline, 500 ml	<1%	2,637	$161.59
C1780	Lens, intraocular (new technology)	<1%	327	$158.66
G0279	Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066)	<1%	143	$155.59
36600		<1%	30	$154.84
76376		<1%	640	$148.88
J7050	Infusion, normal saline solution, 250 cc	<1%	10,107	$145.05
90696		<1%	14	$132.90
36410		<1%	19	$123.80
J7620	Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme	<1%	1,463	$121.40
J1171	Injection, hydromorphone, 0.1 mg	<1%	680	$116.73
J1805	Injection, esmolol hydrochloride, 10 mg	<1%	314	$114.36
93299		<1%	14	$114.02
83935		<1%	35	$111.58
0753T		<1%	368	$109.12
J9267	Injection, paclitaxel, 1 mg	<1%	1,157	$109.10
G0498	Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted living) using a portable pump provided by the office/clinic, includes follow up office/clinic visit at the conclusion of the infusion	<1%	44	$95.68
J2060	Injection, lorazepam, 2 mg	<1%	499	$95.25
J1790	Injection, droperidol, up to 5 mg	<1%	638	$94.42
J0665	Injection, bupivicaine, not otherwise specified, 0.5 mg	<1%	852	$92.28
90710		<1%	16	$91.86
90460	Immunization administration through 18 years of age via any route, first or only component	<1%	79	$90.17
76377		<1%	1,034	$89.94
86147		<1%	26	$86.20
94761		<1%	548	$85.98
82945		<1%	30	$81.72
J1920	Injection, labetalol hydrochloride, 5 mg	<1%	309	$79.25
96411		<1%	1,144	$73.87
87116		<1%	41	$73.24
86593		<1%	18	$71.85
Q4081	Injection, epoetin alfa, 100 units (for esrd on dialysis)	<1%	94	$66.65
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	278	$63.81
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	<1%	184	$63.65
H0048	Alcohol and/or other drug testing: collection and handling only, specimens other than blood	<1%	13	$59.15
J2175	Injection, meperidine hydrochloride, per 100 mg	<1%	607	$58.45
J2470	Injection, pantoprazole sodium, 40 mg	<1%	89	$56.25
83718		<1%	45	$55.67
J2550	Injection, promethazine hcl, up to 50 mg	<1%	285	$55.58
J0330	Injection, succinylcholine chloride, up to 20 mg	<1%	624	$53.05
86146		<1%	14	$47.67
J7040	Infusion, normal saline solution, sterile (500 ml = 1 unit)	<1%	1,651	$47.08
84436		<1%	16	$46.29
82140		<1%	54	$45.01
J1030	Injection, methylprednisolone acetate, 40 mg	<1%	31	$44.46
84157		<1%	49	$40.85
G1004	Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program	<1%	298	$39.30
46600		<1%	160	$38.09
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	<1%	821	$37.49
J2710	Injection, neostigmine methylsulfate, up to 0.5 mg	<1%	448	$32.80
J0613	Injection, calcium gluconate (wg critical care), not therapeutically equivalent to j0612, 10 mg	<1%	72	$32.80
G0500	Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate)	<1%	129	$30.44
A4648	Tissue marker, implantable, any type, each	<1%	372	$30.09
86705		<1%	13	$29.62
29515		<1%	12	$27.03
J2003	Injection, lidocaine hydrochloride, 1 mg	<1%	726	$26.03
90648		<1%	14	$21.03
82950		<1%	15	$17.64
J2001	Injection, lidocaine hcl for intravenous infusion, 10 mg	<1%	779	$16.63
J1596	Injection, glycopyrrolate, 0.1 mg	<1%	276	$14.97
J0173	Injection, epinephrine (belcher), not therapeutically equivalent to j0171, 0.1 mg	<1%	289	$14.33
J0461	Injection, atropine sulfate, 0.01 mg	<1%	207	$12.50
00400		<1%	177	$12.40
J2795	Injection, ropivacaine hydrochloride, 1 mg	<1%	149	$12.28
J0456	Injection, azithromycin, 500 mg	<1%	42	$10.37
J7613	Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg	<1%	443	$10.17
91301		<1%	1,240	$6.65
91307		<1%	624	$5.94
J0171	Injection, adrenalin, epinephrine, 0.1 mg	<1%	470	$4.96
96377		<1%	297	$3.90
36416		<1%	343	$3.32
Q0162	Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen	<1%	22	$3.25
J2004	Injection, lidocaine hcl with epinephrine, 1 mg	<1%	141	$2.83
91305		<1%	132	$1.22
91306		<1%	86	$0.77
J0741	Injection, cabotegravir and rilpivirine, 2mg/3mg	<1%	24	$0.07
A9552	Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries	0%	1,079	$0.00
C1788	Port, indwelling (implantable)	0%	20	$0.00
D1120	Dental cleaning, child	0%	623	$0.00
C1752	Catheter, hemodialysis/peritoneal, short-term	0%	112	$0.00
Q9966	Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml	0%	494	$0.00
00520		0%	221	$0.00
J0736	Injection, clindamycin phosphate, 300 mg	0%	20	$0.00
15853		0%	43	$0.00
00811		0%	91	$0.00
Q0508	Miscellaneous supply or accessory for use with an implanted ventricular assist device	0%	17	$0.00
J0134	Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg	0%	432	$0.00
A4649	Surgical supply; miscellaneous	0%	144	$0.00
01810		0%	24	$0.00
00145		0%	20	$0.00
00140		0%	23	$0.00
00940		0%	18	$0.00
96159		0%	19	$0.00
C1729	Catheter, drainage	0%	28	$0.00
77003		0%	19	$0.00
96138		0%	13	$0.00
96133		0%	13	$0.00
J2371	Injection, phenylephrine hydrochloride, 20 micrograms	0%	63	$0.00
00126		0%	218	$0.00
80050	General health panel	0%	74	$0.00
G0103	Prostate cancer screening; prostate specific antigen test (psa)	0%	12	$0.00
D0272	Bitewings - two radiographic images	0%	267	$0.00
00790		0%	66	$0.00
00160		0%	96	$0.00
00952		0%	79	$0.00
00320		0%	111	$0.00
94760		0%	379	$0.00
01480		0%	80	$0.00
J0610	Injection, calcium gluconate (fresenius kabi), per 10 ml	0%	20	$0.00
C1819	Surgical tissue localization and excision device (implantable)	0%	45	$0.00
J2305	Injection, nitroglycerin, 5 mg	0%	13	$0.00
A9698	Non-radioactive contrast imaging material, not otherwise classified, per study	0%	45	$0.00
J1010	Injection, methylprednisolone acetate, 1 mg	0%	14	$0.00
C1727	Catheter, balloon tissue dissector, non-vascular (insertable)	0%	20	$0.00
96139		0%	13	$0.00
L8699	Prosthetic implant, not otherwise specified	0%	13	$0.00
00813		0%	23	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialSCHILLERO, ANTHONY (DIRECTOR, FP&A)

Same official

Other billing entities under SCHILLERO, ANTHONY

Full network →

Provider	Location	Paid
University Hospitals Cleveland Medical Center	Cleveland, OH	$76.72M
Emh Regional Medical Center	Elyria, OH	$41.46M
University Hospitals Laboratory Services Foundation	Cleveland, OH	$41.07M
Robinson Health System, INC.	Ravenna, OH	$26.26M
Uh Regional Hospitals	Chardon, OH	$23.17M
University Hospitals Ahuja Medical Center, INC	Beachwood, OH	$21.13M
Parma Community General Hospital Association	Parma, OH	$15.68M
University Hospitals ST. John Medical Center	Westlake, OH	$11.77M
Samaritan Regional Health System	Ashland, OH	$10.39M
University Hospitals Geneva Medical Center	Geneva, OH	$9.85M
University Hospitals Home Care Services INC	Warrensville Heights, OH	$7.63M
University Hospitals Conneaut Medical Center	Conneaut, OH	$5.65M
University Hospitals Home Care Services INC	Warrensville Heights, OH	$4.12M
University Hospitals Cleveland Medical Center	Cleveland, OH	$2.88M
Uh Regional Hospitals	Chardon, OH	$2.85M
University Hospitals Home Care Services INC	Warrensville Heights, OH	$1.36M
University Hospitals Critical Care Transport LLC	Shaker Heights, OH	$309K
University Hospitals Cleveland Medical Center	Cleveland, OH	$101K
University Hospitals Laboratory Services Foundation	Cleveland, OH	$58K
University Hospitals ST. John Medical Center	Westlake, OH	$49K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.